Immutep Non Current Liabilities Total vs Total Current Assets Analysis
| IMMP Stock | USD 2.98 0.11 3.83% |
Immutep financial indicator trend analysis is infinitely more than just investigating Immutep Ltd ADR recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immutep Ltd ADR is a good investment. Please check the relationship between Immutep Non Current Liabilities Total and its Total Current Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
Non Current Liabilities Total vs Total Current Assets
Non Current Liabilities Total vs Total Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immutep Ltd ADR Non Current Liabilities Total account and Total Current Assets. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Immutep's Non Current Liabilities Total and Total Current Assets is -0.31. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Immutep Ltd ADR, assuming nothing else is changed. The correlation between historical values of Immutep's Non Current Liabilities Total and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Immutep Ltd ADR are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Non Current Liabilities Total i.e., Immutep's Non Current Liabilities Total and Total Current Assets go up and down completely randomly.
Correlation Coefficient | -0.31 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Non Current Liabilities Total
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Most indicators from Immutep's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immutep Ltd ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. At this time, Immutep's Issuance Of Capital Stock is relatively stable compared to the past year. As of 06/01/2024, Enterprise Value is likely to grow to about 2.6 B, while Selling General Administrative is likely to drop slightly above 9.3 M.
| 2021 | 2023 | 2024 (projected) | Reconciled Depreciation | 3.0M | 3.4M | 2.3M | Net Interest Income | 192.0K | 1.1M | 1.1M |
Immutep fundamental ratios Correlations
Click cells to compare fundamentals
Immutep Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Immutep fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 46.6M | 82.0M | 102.2M | 147.4M | 169.6M | 178.0M | |
| Other Current Liab | 1.6M | 3.3M | 3.4M | 4.1M | 4.8M | 5.0M | |
| Total Current Liabilities | 3.4M | 5.3M | 6.4M | 9.8M | 11.2M | 11.8M | |
| Total Stockholder Equity | 33.3M | 73.3M | 94.1M | 136.5M | 156.9M | 164.8M | |
| Property Plant And Equipment Net | 250.6K | 309.7K | 308.1K | 468.5K | 538.8K | 270.3K | |
| Net Debt | (17.3M) | (57.3M) | (78.3M) | (122.2M) | (110.0M) | (104.5M) | |
| Retained Earnings | (275.7M) | (274.6M) | (302.3M) | (339.9M) | (305.9M) | (290.6M) | |
| Accounts Payable | 1.6M | 1.8M | 2.9M | 5.4M | 6.3M | 6.6M | |
| Cash | 26.3M | 60.1M | 80.0M | 123.4M | 141.9M | 149.0M | |
| Non Current Assets Total | 15.4M | 13.6M | 11.4M | 12.5M | 14.4M | 10.9M | |
| Cash And Short Term Investments | 26.3M | 60.1M | 80.0M | 123.4M | 141.9M | 149.0M | |
| Net Receivables | 3.4M | 6.1M | 8.4M | 8.0M | 9.2M | 9.6M | |
| Common Stock Shares Outstanding | 407.3M | 604.3M | 862.3M | 892.4M | 1.0B | 1.1B | |
| Liabilities And Stockholders Equity | 46.6M | 82.0M | 102.2M | 147.4M | 169.6M | 178.0M | |
| Other Current Assets | 1.4M | 7.8M | 3.6M | 3.6M | 4.1M | 4.3M | |
| Other Stockholder Equity | 33.3M | 73.3M | 38.7M | 39.8M | 35.8M | 38.9M | |
| Total Liab | 13.3M | 8.8M | 8.1M | 11.0M | 12.6M | 7.5M | |
| Property Plant And Equipment Gross | 250.6K | 309.7K | 941.1K | 1.1M | 1.3M | 1.3M | |
| Total Current Assets | 31.2M | 68.4M | 90.8M | 135.0M | 155.2M | 163.0M | |
| Accumulated Other Comprehensive Income | 66.0M | 34.5M | 29.0M | 30.1M | 34.6M | 29.0M | |
| Intangible Assets | 15.1M | 12.7M | 10.4M | 9.4M | 10.8M | 10.1M | |
| Short Long Term Debt Total | 9.1M | 2.8M | 1.7M | 1.2M | 1.4M | 1.3M | |
| Short Term Debt | 129.4K | 208.2K | 173.4K | 185.2K | 166.7K | 228.7K | |
| Non Currrent Assets Other | (15.4M) | 454.2K | 495.7K | 2.5M | 2.9M | 3.0M | |
| Non Current Liabilities Total | 9.9M | 3.4M | 1.7M | 1.2M | 1.4M | 1.3M | |
| Other Liab | 1.0M | 811.9K | 117.3K | 164.4K | 189.1K | 179.6K | |
| Common Stock | 243.0M | 313.4M | 367.4M | 446.3M | 513.2M | 538.9M | |
| Property Plant Equipment | 250.6K | 309.7K | 308.1K | 468.5K | 421.7K | 227.9K | |
| Common Stock Total Equity | 213.2M | 221.1M | 233.3M | 313.4M | 360.4M | 225.2M | |
| Net Tangible Assets | 18.1M | 60.4M | 83.5M | 127.0M | 146.0M | 153.3M | |
| Long Term Debt | 8.8M | 2.5M | 2.1M | 835.4K | 751.9K | 714.3K | |
| Capital Lease Obligations | 262.4K | 288.3K | 408.3K | 392.8K | 451.7K | 474.3K | |
| Net Invested Capital | 42.1M | 75.8M | 138.9M | 137.3M | 157.9M | 165.8M | |
| Net Working Capital | 27.8M | 63.1M | 122.7M | 125.2M | 144.0M | 151.2M | |
| Capital Stock | 243.0M | 313.4M | 534.1M | 446.3M | 513.2M | 386.7M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Immutep Stock analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Immutep's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immutep. If investors know Immutep will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immutep listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share 0.04 | Quarterly Revenue Growth 0.252 | Return On Assets (0.26) | Return On Equity (0.42) |
The market value of Immutep Ltd ADR is measured differently than its book value, which is the value of Immutep that is recorded on the company's balance sheet. Investors also form their own opinion of Immutep's value that differs from its market value or its book value, called intrinsic value, which is Immutep's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immutep's market value can be influenced by many factors that don't directly affect Immutep's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immutep's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immutep is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immutep's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.